These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Comparison of MRI-based thrombolysis for patients with middle cerebral artery occlusionLi YH; Li MH; Zhao ZG; Bai QK Neurol India; 2009; 57(4):426-33. PubMed ID: 19770543 [TBL] [Abstract][Full Text] [Related]
11. Simple clinical predictors of stroke outcome based on National Institutes of Health Stroke scale score during 1-h recombinant tissue-type plasminogen activator infusion. Osaki M; Miyashita F; Koga M; Fukuda M; Shigehatake Y; Nagatsuka K; Minematsu K; Toyoda K Eur J Neurol; 2014 Mar; 21(3):411-8. PubMed ID: 24200315 [TBL] [Abstract][Full Text] [Related]
12. Arterial occlusion sites on magnetic resonance angiography influence the efficacy of intravenous low-dose (0.6 mg/kg) alteplase therapy for ischaemic stroke. Nakashima T; Toyoda K; Koga M; Matsuoka H; Nagatsuka K; Takada T; Naritomi H; Minematsu K Int J Stroke; 2009 Dec; 4(6):425-31. PubMed ID: 19930051 [TBL] [Abstract][Full Text] [Related]
13. Hemorrhagic transformation of ischemic brain tissue after t-PA thrombolysis as detected by MRI may be asymptomatic, but impair neurological recovery. Kimura K; Iguchi Y; Shibazaki K; Aoki J; Terasawa Y J Neurol Sci; 2008 Sep; 272(1-2):136-42. PubMed ID: 18602647 [TBL] [Abstract][Full Text] [Related]
14. CHADS2 score is associated with 3-month clinical outcomes after intravenous rt-PA therapy in stroke patients with atrial fibrillation: SAMURAI rt-PA Registry. Koga M; Kimura K; Shibazaki K; Shiokawa Y; Nakagawara J; Furui E; Yamagami H; Okada Y; Hasegawa Y; Kario K; Okuda S; Naganuma M; Nezu T; Maeda K; Minematsu K; Toyoda K J Neurol Sci; 2011 Jul; 306(1-2):49-53. PubMed ID: 21492878 [TBL] [Abstract][Full Text] [Related]
15. Prediction of long-term outcome by percent improvement after the first day of thrombolytic treatment in stroke patients. Nam HS; Lee KY; Han SW; Kim SH; Lee JY; Ahn SH; Kim DJ; Kim DI; Nam CM; Heo JH J Neurol Sci; 2009 Jun; 281(1-2):69-73. PubMed ID: 19304298 [TBL] [Abstract][Full Text] [Related]
16. Predictors of major neurological improvement after intravenous thrombolysis in acute ischemic stroke: a hospital-based study from south India. Boddu DB; Srinivasarao Bandaru VC; Reddy PG; Madhusudan M; Rukmini MK; Suryaprabha T; Jabeen SA; Suvarna A; Jayalakshmi SS; Meena AK; Borgohain R; Kaul S Neurol India; 2010; 58(3):403-6. PubMed ID: 20644268 [TBL] [Abstract][Full Text] [Related]
17. Recombinant tissue plasminogen activator for minor strokes: the National Institute of Neurological Disorders and Stroke rt-PA Stroke Study experience. National Institute of Neurological Disorders Stroke rt-PA Stroke Study Group Ann Emerg Med; 2005 Sep; 46(3):243-52. PubMed ID: 16126134 [TBL] [Abstract][Full Text] [Related]
18. Does ICA occlusion frequently have intracerebral hemorrhage after IV tissue plasminogen activator therapy for ischemic stroke? Kimura K; Sakai K; Iguchi Y; Shibazaki K; Sakamoto Y Eur Neurol; 2011; 65(5):245-9. PubMed ID: 21464569 [TBL] [Abstract][Full Text] [Related]
19. Initial Glasgow Coma Scale score predicts outcome following thrombolysis for posterior circulation stroke. Tsao JW; Hemphill JC; Johnston SC; Smith WS; Bonovich DC Arch Neurol; 2005 Jul; 62(7):1126-9. PubMed ID: 16009770 [TBL] [Abstract][Full Text] [Related]
20. Recanalization of the MCA should play an important role in dramatic recovery after t-PA therapy in patients with ICA occlusion. Kimura K; Iguchi Y; Shibazaki K; Iwanaga T; Aoki J J Neurol Sci; 2009 Oct; 285(1-2):130-3. PubMed ID: 19573877 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]